"Colitis, Ulcerative" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.
| Descriptor ID |
D003093
|
| MeSH Number(s) |
C06.405.205.265.231 C06.405.205.731.249 C06.405.469.158.188.231 C06.405.469.432.249
|
| Concept/Terms |
Colitis, Ulcerative- Colitis, Ulcerative
- Idiopathic Proctocolitis
- Ulcerative Colitis
- Colitis Gravis
- Inflammatory Bowel Disease, Ulcerative Colitis Type
|
Below are MeSH descriptors whose meaning is more general than "Colitis, Ulcerative".
Below are MeSH descriptors whose meaning is more specific than "Colitis, Ulcerative".
This graph shows the total number of publications written about "Colitis, Ulcerative" by people in this website by year, and whether "Colitis, Ulcerative" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 8 | 0 | 8 |
| 1996 | 5 | 3 | 8 |
| 1997 | 3 | 0 | 3 |
| 1998 | 7 | 2 | 9 |
| 1999 | 4 | 2 | 6 |
| 2000 | 6 | 0 | 6 |
| 2001 | 8 | 2 | 10 |
| 2002 | 6 | 1 | 7 |
| 2003 | 11 | 1 | 12 |
| 2004 | 12 | 0 | 12 |
| 2005 | 6 | 4 | 10 |
| 2006 | 15 | 1 | 16 |
| 2007 | 12 | 4 | 16 |
| 2008 | 11 | 2 | 13 |
| 2009 | 10 | 3 | 13 |
| 2010 | 9 | 0 | 9 |
| 2011 | 22 | 3 | 25 |
| 2012 | 11 | 1 | 12 |
| 2013 | 13 | 2 | 15 |
| 2014 | 8 | 0 | 8 |
| 2015 | 7 | 4 | 11 |
| 2016 | 21 | 5 | 26 |
| 2017 | 17 | 4 | 21 |
| 2018 | 13 | 1 | 14 |
| 2019 | 19 | 4 | 23 |
| 2020 | 23 | 2 | 25 |
| 2021 | 25 | 1 | 26 |
| 2022 | 28 | 0 | 28 |
| 2023 | 22 | 0 | 22 |
| 2024 | 20 | 5 | 25 |
| 2025 | 15 | 1 | 16 |
To return to the timeline,
click here.
Below are the most recent publications written about "Colitis, Ulcerative" by people in Profiles.
-
Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative Colitis. Inflamm Bowel Dis. 2025 Jun 13; 31(6):1630-1636.
-
Health-Related Quality of Life Outcomes With Etrasimod Treatment in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From ELEVATE UC 52 and ELEVATE UC 12. Inflamm Bowel Dis. 2025 Jun 13; 31(6):1583-1594.
-
Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY). J Crohns Colitis. 2025 Jun 04; 19(6).
-
Deucravacitinib in patients with inflammatory bowel disease: 12-week efficacy and safety results from 3 randomized phase 2 studies in Crohn's disease and ulcerative colitis. J Crohns Colitis. 2025 Jun 04; 19(6).
-
The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical Program. Inflamm Bowel Dis. 2025 Apr 10; 31(4):923-934.
-
Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis. J Crohns Colitis. 2025 Apr 04; 19(4).
-
Mirikizumab in the Treatment of Ulcerative Colitis: Initial Real-World Data in a Population from a Large Tertiary Center. Dig Dis Sci. 2025 May; 70(5):1864-1872.
-
Etrasimod Corticosteroid-Free Efficacy, Impact of Concomitant Corticosteroids on Efficacy and Safety, and Corticosteroid-Sparing Effect in Ulcerative Colitis: Analyses of the ELEVATE UC Clinical Program. J Crohns Colitis. 2025 Mar 05; 19(3).
-
Genetic polymorphisms impacting clinical pharmacology of drugs used to treat inflammatory bowel disease: a precursor to multi-omics approach to precision medicine. Expert Rev Clin Immunol. 2025 Apr; 21(4):461-472.
-
Multiomic analysis reveals cellular, transcriptomic and epigenetic changes in intestinal pouches of ulcerative colitis patients. Nat Commun. 2025 Jan 21; 16(1):904.